Arbutus Biopharma Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arbutus Biopharma

ABUS 4.615

+0.5%

Oct 29 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: donpat	3/4/2015 9:14:15 PM
	of 42

Tekmira Pharmaceuticals Corp Price Target Update by Thomas Lindt on March 4, 2015 Tekmira Pharmaceuticals Corp (NASDAQ:TKMR): According to 5 Analysts, The short term target price has been estimated at $ 31.6.The target price could deviate by a maximum of $5.86 from the forecast price. In the near term, the target price could hit a high of $40 and a low of $ 26. wallstreetpulse.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next